Bask­ing in praise and a $4.2B GSK pact, Mer­ck KGaA blue­prints ex­pan­sion plans for Boston-area R&D cam­pus

Fresh on the heels of an­nounc­ing a multi­bil­lion-dol­lar de­vel­op­ment pact with Glax­o­SmithK­line, Mer­ck KGaA is show­ing off its blue­print for a big ex­pan­sion of its R&D op­er­a­tions in Bil­ler­i­ca, out­side of Boston.

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.